Patients with unresectable or metastatic leiomyosarcoma (LMS). There is no age requirement
Receiving first-line chemotherapy with doxorubicin- based or gemcitabine/docetaxel
Target lesions per RECIST 1.1
Optional archival tumor tissue including 1 H\&E-stained slide and unstained tumor tissue \[either tissue block containing tumor, or minimum of 4 unstained slides (preferably 8 unstained slides)-fresh frozen sample may also be used in lieu of FFPE sample\] available for study research
Clareo Health | Metastatic Leiomyosarcoma Biomarker Protocol
